Endologix Inc (ELGX)

7.04
0.01 0.14
NASDAQ : Health Care
Prev Close 7.05
Open 7.14
Day Low/High 6.98 / 7.17
52 Wk Low/High 6.50 / 14.89
Volume 487.48K
Avg Volume 1.37M
Exchange NASDAQ
Shares Outstanding 82.69M
Market Cap 571.40M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

January 2017 Options Now Available For Endologix (ELGX)

January 2017 Options Now Available For Endologix (ELGX)

Investors in Endologix Inc. saw new options begin trading today, for the January 2017 expiration.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Endologix Inc. - ELGX

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Endologix Inc. - ELGX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Endologix Inc.

Endologix Breaks Below 200-Day Moving Average - Notable for ELGX

Endologix Breaks Below 200-Day Moving Average - Notable for ELGX

In trading on Friday, shares of Endologix Inc. crossed below their 200 day moving average of $11.07, changing hands as low as $10.58 per share.

Oversold Conditions For Endologix (ELGX)

Oversold Conditions For Endologix (ELGX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of ELGX December 16th Options Trading

First Week Of ELGX December 16th Options Trading

Investors in Endologix Inc. saw new options become available this week, for the December 16th expiration.

Endologix Announces First Patients Treated With Ovation Alto™ Abdominal Stent Graft System

Endologix Announces First Patients Treated With Ovation Alto™ Abdominal Stent Graft System

Ovation Alto™ Designed to Expand EVAR to Include the Treatment of Patients with Complex AAAs

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Energy, financial and technology stocks dominate names showing potential for higher prices.

Strong On High Relative Volume: Endologix (ELGX)

Strong On High Relative Volume: Endologix (ELGX)

Trade-Ideas LLC identified Endologix (ELGX) as a strong on high relative volume candidate

Why Endologix (ELGX) Stock Is Tumbling Today

Why Endologix (ELGX) Stock Is Tumbling Today

Endologix (ELGX) posted better-than-expected results for the 2016 second quarter, but the timeline for its Nellix device to be approved is more drawn out than previously anticipated.

Analysts' Actions -- Bruker, Endologix, Mosaic, Trex and More

Analysts' Actions -- Bruker, Endologix, Mosaic, Trex and More

Here are Wednesday's top research calls, including downgrades for Bruker, Endologix, Mosaic and Trex.

Endologix Reports Results For The Second Quarter 2016

Endologix Reports Results For The Second Quarter 2016

Global Revenue Reaches $51 Million, Raises Guidance for Full Year 2016 Revenue

Analysts' Actions -- First Solar, Qualcomm, Red Hat, Zions and More

Analysts' Actions -- First Solar, Qualcomm, Red Hat, Zions and More

Here are Thursday's top research calls, including an upgrade for Zions, and downgrades for First Solar, Qualcomm and Red Hat.

Endologix (ELGX) Highlighted As Weak On High Volume

Endologix (ELGX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Endologix (ELGX) as a weak on high relative volume candidate

Endologix (ELGX) Is Today's Strong On High Volume Stock

Endologix (ELGX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Endologix (ELGX) as a strong on high relative volume candidate

Analysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More

Analysts' Actions -- Agios Pharma, Concho Resources, Occidental, Sprouts and More

Here are Monday's top research calls, including upgrades for Agios Pharmaceuticals and Concho Resources, and downgrades for Occidental Petroleum and Sprouts Farmers Market.